Literature DB >> 22212643

Quantification of systemic delivery of substrates for intermediate metabolism during citrate anticoagulation of continuous renal replacement therapy.

Martin Balik1, Mykhaylo Zakharchenko, Michal Otahal, Jan Hruby, Ferdinand Polak, Katerina Rusinova, Zdenek Stach, Jaroslava Vavrova, Antonin Jabor.   

Abstract

BACKGROUND: There are limited data on systemic delivery of metabolic substrates during citrate anticoagulation. The direct citrate measurements are usually not available.
METHODS: Patients on 2.2% acid-citrate-dextrose (ACD, n = 41) were compared to a control group on unfractionated heparin (n = 17). All were treated on 1.9-m(2) polysulfone filters. Samples were taken from the central venous catheter, ports pre- and post-filter and from effluent.
RESULTS: The gain of citrate in CVVH (n = 18) was not different from CVVHDF (n = 23, p = 0.8). Mean gain of citrate was 25.4 ± 6.4 mmol/h. The systemic loads of lactate (p = 0.12) and glucose (p = 0.23) in CVVH were similar to CVVHDF. Mean inputs of lactate and glucose were 62.9 ± 21.1 and 26.6 ± 10.4 mmol/h, respectively. The mean difference between post- and prefilter unmeasured anions (d-UA) correlated with mean difference of citrate concentrations (p < 0.0001, r(2) = 0.66). The estimated caloric load of the citrate modalities was 5,536 ± 1,385 kJ/ 24 h.
CONCLUSIONS: ACD might represent a significant load of metabolic substrates, particularly if used with lactate buffer. Systemic delivery of citrate can be predicted using d-UA in the extracorporeal circuit.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22212643     DOI: 10.1159/000334641

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  8 in total

1.  Continuous renal replacement therapy: a potential source of calories in the critically ill.

Authors:  Andrea M New; Erin M Nystrom; Erin Frazee; John J Dillon; Kianoush B Kashani; John M Miles
Journal:  Am J Clin Nutr       Date:  2017-05-03       Impact factor: 7.045

Review 2.  Clinical review: anticoagulation for continuous renal replacement therapy--heparin or citrate?

Authors:  Heleen M Oudemans-van Straaten; John A Kellum; Rinaldo Bellomo
Journal:  Crit Care       Date:  2011-01-24       Impact factor: 9.097

3.  Simplified Citrate Anticoagulation for CRRT Without Calcium Replacement.

Authors:  Marcus Broman; Bengt Klarin; Karin Sandin; Ola Carlsson; Anders Wieslander; Jan Sternby; Gabriela Godaly
Journal:  ASAIO J       Date:  2015 Jul-Aug       Impact factor: 2.872

4.  Low concentrations of citrate reduce complement and granulocyte activation in vitro in human blood.

Authors:  Shan Huang; Kerstin Sandholm; Nina Jonsson; Anders Nilsson; Anders Wieslander; Gunilla Grundström; Viktoria Hancock; Kristina N Ekdahl
Journal:  Clin Kidney J       Date:  2014-12-01

5.  The Effects of High Level Magnesium Dialysis/Substitution Fluid on Magnesium Homeostasis under Regional Citrate Anticoagulation in Critically Ill.

Authors:  Mychajlo Zakharchenko; Ferdinand Los; Helena Brodska; Martin Balik
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

6.  A Rare Case of Severe Metabolic Alkalosis with Unusual Hyperproteinemia Treated with Continuous Renal Replacement Therapy and Regional Citrate Anticoagulation.

Authors:  Vojtěch Matoušek; Ivan Herold; Lenka Holanová; Martin Balík
Journal:  Case Rep Nephrol Dial       Date:  2018-08-03

7.  Bench-to-bedside review: Citrate for continuous renal replacement therapy, from science to practice.

Authors:  Heleen M Oudemans-van Straaten; Marlies Ostermann
Journal:  Crit Care       Date:  2012-12-07       Impact factor: 9.097

8.  Complications of regional citrate anticoagulation: accumulation or overload?

Authors:  Antoine G Schneider; Didier Journois; Thomas Rimmelé
Journal:  Crit Care       Date:  2017-11-19       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.